Emerging World Pharma Stock Performance
| EWPI Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Emerging World are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Emerging World Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Emerging World is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
Emerging World Relative Risk vs. Return Landscape
If you would invest 0.01 in Emerging World Pharma on November 1, 2025 and sell it today you would earn a total of 0.00 from holding Emerging World Pharma or generate 0.0% return on investment over 90 days. Emerging World Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Emerging, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Emerging World Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emerging World for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emerging World Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Emerging World generated a negative expected return over the last 90 days | |
| Emerging World has some characteristics of a very speculative penny stock | |
| Emerging World has a very high chance of going through financial distress in the upcoming years | |
| Emerging World Pharma currently holds 3.2 M in liabilities. Emerging World Pharma has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Emerging World's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (410.32 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Emerging World Pharma currently holds about 118.42 K in cash with (138.59 K) of positive cash flow from operations. |
Emerging World Fundamentals Growth
Emerging Stock prices reflect investors' perceptions of the future prospects and financial health of Emerging World, and Emerging World fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Emerging Stock performance.
| Current Valuation | 2.15 M | |||
| Shares Outstanding | 119.3 M | |||
| Cash And Equivalents | 118.42 K | |||
| Total Debt | 3.2 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (138.59 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 2.71 M | |||
| Retained Earnings | (1.71 M) | |||
| Current Liabilities | 4.07 M | |||
About Emerging World Performance
By evaluating Emerging World's fundamental ratios, stakeholders can gain valuable insights into Emerging World's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Emerging World has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Emerging World has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Emerging World Pharma, Inc. invests in generic based pharmaceutical companies manufacturing within developing nations. The company was founded in 1997 and is based in Sunyani, Ghana. Emerging World is traded on OTC Exchange in the United States.Things to note about Emerging World Pharma performance evaluation
Checking the ongoing alerts about Emerging World for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Emerging World Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Emerging World generated a negative expected return over the last 90 days | |
| Emerging World has some characteristics of a very speculative penny stock | |
| Emerging World has a very high chance of going through financial distress in the upcoming years | |
| Emerging World Pharma currently holds 3.2 M in liabilities. Emerging World Pharma has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Emerging World's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (410.32 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Emerging World Pharma currently holds about 118.42 K in cash with (138.59 K) of positive cash flow from operations. |
- Analyzing Emerging World's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Emerging World's stock is overvalued or undervalued compared to its peers.
- Examining Emerging World's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Emerging World's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Emerging World's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Emerging World's stock. These opinions can provide insight into Emerging World's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Emerging Stock analysis
When running Emerging World's price analysis, check to measure Emerging World's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emerging World is operating at the current time. Most of Emerging World's value examination focuses on studying past and present price action to predict the probability of Emerging World's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emerging World's price. Additionally, you may evaluate how the addition of Emerging World to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |